Ryan Adist

About the Author Ryan Adist


Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Crispr Therapeutics AG (CRSP)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Crispr …

BMO Capital Reiterates Their Buy Rating on MAG Silver (MAG)

In a report released today, Ryan Thompson from BMO Capital reiterated a Buy rating on MAG Silver (MAG), with a price target of …

Piper Jaffray’s Take on This Canadian Energy Stock

Piper Jaffray analyst Pearce Hammond maintained a Hold rating on NGL Energy Partners (NGL) today and set a price target of $13.00.

Meridian Bioscience (VIVO) Gets a Sell Rating from Canaccord Genuity

In a report released today, Mark Massaro from Canaccord Genuity maintained a Sell rating on Meridian Bioscience (VIVO), with a price target of …

Guggenheim Keeps Their Buy Rating on PVH (PVH)

Guggenheim analyst Robert Drbul maintained a Buy rating on PVH (PVH) today and set a price target of $125.00.

Needham Sticks to Its Buy Rating for Alteryx (AYX)

In a report released yesterday, Jack Andrews from Needham reiterated a Buy rating on Alteryx (AYX), with a price target of $140.00.

Cowen & Co. Keeps Their Buy Rating on Frequency Therapeutics (FREQ)

In a report released today, Phil Nadeau from Cowen & Co. maintained a Buy rating on Frequency Therapeutics (FREQ).

Ladenburg Thalmann Financial (LTS) Gets a Hold Rating from Barrington

In a report released today, Alexander Paris from Barrington maintained a Hold rating on Ladenburg Thalmann Financial (LTS). The company’s shares closed last …

Analysts Offer Insights on Services Companies: Humana (HUM) and LATAM Airlines (LTM)

Analysts fell to the sidelines weighing in on Humana (HUM) and LATAM Airlines (LTM) with neutral ratings, indicating that the experts are neither …

Merrill Lynch Keeps Their Buy Rating on BeiGene (BGNE)

In a report released today, Yang Huang from Merrill Lynch maintained a Buy rating on BeiGene (BGNE), with a price target of $230.00.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts